K Wyatt Engwall insider trades: Theragenics (TGX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where K reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 3, 2010 | TGX | ↑ Buy | 1,250 | $1.16 | $1K | Direct | Jun 4, 2010 (1d) |
| Jun 1, 2010 | TGX | ↑ Buy | 26,200 | $1.19 | $31K | Direct | Jun 3, 2010 (2d) |
| Feb 19, 2010 | TGX | ↑ Buy | 50,000 | $1.35 | $67K | Direct | Feb 22, 2010 (3d) |
| Nov 6, 2008 | TGX | ↑ Buy | 21,100 | $1.41 | $30K | Direct | Nov 7, 2008 (1d) |
| Aug 28, 2008 | TGX | ↑ Buy | 21,000 | $3.34 | $70K | Direct | Aug 28, 2008 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About K Wyatt Engwall's insider trades
K Wyatt Engwall is a director at Theragenics (TGX). Since Aug 28, 2008, K has reported 5 open-market purchases worth $200K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TGX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.